APA

Chrispijn M., Nevens F., Gevers T. J. G., Vanslembrouck R., van Oijen M. G. H., Coudyzer W., Hoffmann A. L., Dekker H. M., de Man R. A., van Keimpema L. & Drenth J. P. H. (20120413). The long-term outcome of patients with polycystic liver disease treated with lanreotide. : Alimentary pharmacology & therapeutics.

Chicago

Chrispijn M, Nevens F, Gevers T J G, Vanslembrouck R, van Oijen M G H, Coudyzer W, Hoffmann A L, Dekker H M, de Man R A, van Keimpema L and Drenth J P H. 20120413. The long-term outcome of patients with polycystic liver disease treated with lanreotide. : Alimentary pharmacology & therapeutics.

Harvard

Chrispijn M., Nevens F., Gevers T. J. G., Vanslembrouck R., van Oijen M. G. H., Coudyzer W., Hoffmann A. L., Dekker H. M., de Man R. A., van Keimpema L. and Drenth J. P. H. (20120413). The long-term outcome of patients with polycystic liver disease treated with lanreotide. : Alimentary pharmacology & therapeutics.

MLA

Chrispijn M, Nevens F, Gevers T J G, Vanslembrouck R, van Oijen M G H, Coudyzer W, Hoffmann A L, Dekker H M, de Man R A, van Keimpema L and Drenth J P H. The long-term outcome of patients with polycystic liver disease treated with lanreotide. : Alimentary pharmacology & therapeutics. 20120413.